Redukcja ryzyka powikłań nerkowych cukrzycy typu 2 – nowe wyniki badania ADVANCE

ADVANCE Collaborative Group – Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes Journal of the American Society of Nephrology, published ahead of print

In conclusion, BP-lowering treatment with perindopril-indapamide administered routinely to individuals with type 2 diabetes provides important renoprotection, even among those with initial BP <120/70 mmHg. We could not identify a BP threshold below which renal benefit is lost.

Opracowane na podstawie: Journal of the American Society of Nephrology, published ahead of print / 2009-02-19